Tag:
Hizentra
Latest Headlines
Latest Headlines
CSL to boost Hizentra capacity in bid for market share
Patient convenience is a key strategy for drugmakers looking to boost sales: Think Novartis' ( $NVS ) newly approved multiple sclerosis treatment Gilenya, for example; as a pill rather than an injected
